Transamerica Financial Advisors LLC Invests $541,000 in Oracle Corporation $ORCL

Transamerica Financial Advisors LLC bought a new position in Oracle Corporation (NYSE:ORCLFree Report) during the 2nd quarter, HoldingsChannel reports. The fund bought 3,691 shares of the enterprise software provider’s stock, valued at approximately $541,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ORCL. Corient Private Wealth LP purchased a new stake in Oracle during the 2nd quarter valued at $186,175,000. Punch & Associates Investment Management Inc. purchased a new position in shares of Oracle in the second quarter valued at about $8,755,000. Palogic Value Management L.P. purchased a new position in shares of Oracle in the second quarter valued at about $366,000. Perennial Investment Advisors LLC bought a new position in shares of Oracle during the second quarter valued at about $1,610,000. Finally, Pingora Partners LLC bought a new position in shares of Oracle during the second quarter valued at about $689,000. 42.44% of the stock is currently owned by institutional investors.

More Oracle News

Here are the key news stories impacting Oracle this week:

  • Positive Sentiment: Citigroup identifies a potential rebound. Citi initiated a 90-day positive catalyst watch, maintained its Buy rating and reiterated a $330 price target. The firm views Oracle’s roughly 50% decline as an unusually severe selloff and believes negative expectations are largely reflected in the stock, creating an opportunity ahead of upcoming results and the company’s late-October investor day. Oracle Stock Gained 3% on Wednesday, Technical Indicators Point to Further Upside
  • Positive Sentiment: AI demand and backlog support the long-term bull case. Reports highlighted Oracle’s approximately $638 billion contracted backlog and its growing role in AI data-center infrastructure. Investors are weighing the potential for substantial future cloud revenue against the cost and timing of building the required capacity. Oracle Jumps as $638 Billion Backlog Outruns Cash Burn
  • Positive Sentiment: Oracle expanded a major U.S. government healthcare agreement. Oracle Health secured a potential $17 billion expansion of its Department of Veterans Affairs electronic health-record contract, increasing its exposure to a large, long-term public-sector customer. Oracle Secures $17 Billion VA Contract Expansion
  • Neutral Sentiment: Technical and industry factors are improving but remain uncertain. Technical indicators point to possible further upside, and Oracle’s Deutsche Bank technology conference presentation kept attention on its cloud and AI strategy. Still, broader software stocks remain highly volatile as momentum trading and uncertainty over AI economics amplify price swings. Momentum and Leveraged Trading Keep Software Stocks on a Roller Coaster
  • Negative Sentiment: Heavy AI infrastructure spending remains the principal concern. Oracle must finance data-center construction before much of its contracted revenue is recognized, potentially pressuring near-term profits and free cash flow. Project delays and questions about the pace of AI monetization could limit the recovery if execution disappoints.

Insider Activity

In related news, Vice Chairman Jeffrey Henley sold 400,000 shares of Oracle stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $159.16, for a total transaction of $63,664,000.00. Following the completion of the transaction, the insider directly owned 400,000 shares of the company’s stock, valued at $63,664,000. This trade represents a 50.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 40.90% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. UBS Group reissued an “outperform” rating on shares of Oracle in a research note on Friday, August 21st. Scotiabank reaffirmed an “overweight” rating on shares of Oracle in a research report on Thursday, June 11th. Wedbush cut their price objective on Oracle from $275.00 to $240.00 and set an “outperform” rating on the stock in a research report on Thursday, June 11th. BMO Capital Markets upped their target price on Oracle from $200.00 to $220.00 and gave the company an “outperform” rating in a report on Thursday, June 11th. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Oracle in a research note on Thursday, June 11th. Two research analysts have rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Oracle presently has a consensus rating of “Moderate Buy” and an average price target of $263.97.

Get Our Latest Stock Report on ORCL

Oracle Stock Up 2.9%

Shares of NYSE:ORCL opened at $148.90 on Thursday. Oracle Corporation has a 52-week low of $114.50 and a 52-week high of $345.72. The firm has a market capitalization of $428.90 billion, a P/E ratio of 25.54, a P/E/G ratio of 0.91 and a beta of 1.72. The stock has a 50 day moving average price of $142.06 and a 200-day moving average price of $160.60. The company has a debt-to-equity ratio of 3.21, a quick ratio of 1.12 and a current ratio of 1.12.

Oracle (NYSE:ORCLGet Free Report) last released its quarterly earnings results on Wednesday, June 10th. The enterprise software provider reported $2.11 earnings per share for the quarter, beating the consensus estimate of $1.96 by $0.15. The company had revenue of $19.18 billion for the quarter, compared to analyst estimates of $19.10 billion. Oracle had a return on equity of 58.62% and a net margin of 25.37%.The firm’s revenue was up 20.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.70 earnings per share. Oracle has set its Q1 2027 guidance at 1.720-1.760 EPS and its FY 2027 guidance at 8.050-8.050 EPS. As a group, equities research analysts anticipate that Oracle Corporation will post 6.49 EPS for the current fiscal year.

Oracle Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, July 24th. Stockholders of record on Friday, July 10th were given a $0.50 dividend. The ex-dividend date of this dividend was Friday, July 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.3%. Oracle’s dividend payout ratio is currently 34.31%.

Oracle Profile

(Free Report)

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.

Featured Stories

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.